MedTrace Logo

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

NCT01111032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2013-10-01

No results posted yet for this study

Summary

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Oren Cheifetz, M.Sc. PT · Hamilton Health Sciences Corporation

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01111032 on ClinicalTrials.gov